Citation Impact
Citing Papers
Breast cancer
2019 Standout
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
2015
The Roland–Morris Disability Questionnaire and the Oswestry Disability Questionnaire
2000 Standout
Pathophysiology of pruritus in atopic dermatitis: an overview
2002
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
2008
Atopic Dermatitis
2008 Standout
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial
2006
IL-31: A new link between T cells and pruritus in atopic skin inflammation
2006 Standout
Breast cancer
2016 Standout
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Atopic dermatitis
2003 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
2012
Cancer to bone: a fatal attraction
2011 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Bone Cancer Pain: From Model to Mechanism to Therapy
2005
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease
1999
Atopic dermatitis
2015 Standout
Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials
2005
Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome
2007 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
C‐Reactive Protein (CRP)‐Lowering Agents
2006
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
The Oswestry Disability Index
2000 Standout
Biomedical applications of biodegradable polymers
2011 Standout
Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration
2004
Chronic kidney disease
2011 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord
2000
Pathophysiology and therapy of pruritus in allergic and atopic diseases
2010
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Validation of the Korean Version of the Oswestry Disability Index
2005
Zoledronic-Acid-Induced Circulating Level Modifications of Angiogenic Factors, Metalloproteinases and Proinflammatory Cytokines in Metastatic Breast Cancer Patients
2005
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis
2001
The Oswestry Disability Index, the Roland-Morris Disability Questionnaire, and the Quebec Back Pain Disability Scale: Translation and Validation Studies of the Iranian Versions
2006 Standout
Barrier Function and Water-Holding and Transport Properties of Infant Stratum Corneum Are Different from Adult and Continue to Develop through the First Year of Life
2008 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Antiresorptives and Osteonecrosis of the Jaw
2012
Multitargeted therapy of cancer by silymarin
2008 Standout
Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain
2002
In vivo local co-delivery of recombinant human bone morphogenetic protein-7 and pamidronate via poly-D, L-lactic acid
2010
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
The RAAS in the pathogenesis and treatment of diabetic nephropathy
2010
Surface treatments of titanium dental implants for rapid osseointegration
2006 Standout
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment
2014
Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial
2005
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Three Years Follow-up of Pamidronate Therapy in Two Brothers with Osteoporosis-Pseudoglioma Syndrome (OPPG) Carrying an LRP5 Mutation
2008
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis
2002
Randomized, Double-Blind, Placebo-Controlled Crossover Study in Men with Prostate Cancer and Rising PSA: Effectiveness of a Dietary Supplement
2005
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction
2011
Arterial Stiffness and Cardiovascular Events
2010 Standout
American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma
2002
Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: A meta-analysis of randomized clinical trials
2010
Correlative imaging of ionic transport and electronic structure in nano Li0.5FePO4 electrodes
2019 StandoutNobel
Guidelines for the Primary Prevention of Stroke
2014 Standout
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation
2005
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis
2005
Pathological Ventricular Remodeling
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Mechanisms of Diabetic Complications
2013 Standout
The Metabolic Syndrome
2008 Standout
Multiple Myeloma
2011 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Prognostic Impact of Aortic Stiffness in High-Risk Type 2 Diabetic Patients
2013
Oral bisphosphonates
2000
Comparison of multifidus muscle atrophy and trunk extension muscle strength: percutaneous versus open pedicle screw fixation.
2005
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Macrolactam Immunomodulators (Tacrolimus and Pimecrolimus): New Horizons in the Topical Treatment of Inflammatory Skin Diseases
2004
A systematic review of the role of bisphosphonates in metastatic disease
2004
Works of Albert Kandra being referenced
Interaction Between Baseline and Early Worsening of Renal Function and Efficacy of Renin–Angiotensin–Aldosterone System Blockade in Patients with Heart Failure: Insights from the Val-HeFT Study
2013
An In Vitro and In Vivo Study of Cytokines in the Acute-Phase Response Associated with Bisphosphonates
1997
A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer
1998
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis
2001
Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus
2007
Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double‐blind placebo‐controlled trial
1998
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: The VAST study
2005
Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study
2010
Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?
2000
Valsartan Improves Arterial Stiffness in Type 2 Diabetes Independently of Blood Pressure Lowering
2008